E. Vidal Blanco

Risk of SARS-CoV-2 transmission by fomites: a clinical observational study in highly infectious COVID-19 patients

D. Todt, S. Pfaender, E. Steinmann, 2022, medRxiv.

Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination

U. Stervbo, N. Babel, T. Westhoff, 2022, RMD Open.

In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant

U. Stervbo, N. Babel, M. Hoffmann, 2022, Frontiers in Immunology.

Longitudinal data on humoral response and neutralizing antibodies against SARS-CoV-2 Omicron BA.1 and subvariants BA.4/5 and BQ.1.1 after COVID-19 vaccination in cancer patients

S. Pfaender, E. Steinmann, A. Reinacher-Schick, 2023, Journal of Cancer Research and Clinical Oncology.